Table 3.
Entire Patient Group | IGF-1 and IGFBP-3 |
IGF-1 and Cholecalciferol |
IGF-1 and Calcidiol | IGF-1 and Calcitriol |
IGF-1 and Age | IGF-1 and BMI 4 |
---|---|---|---|---|---|---|
Spearman’s r coefficient | 0.25 | −0.23 | 0.05 | −0.31 | −0.40 | −0.05 |
p | 0.01 | 0.03 | 0.63 | 0.003 | 0.0001 | 0.61 |
Entire patient group | IGFBP-3 and cholecalciferol | IGFBP-3 and calcidiol | IGFBP-3 and calcitriol | IGFBP-3 and age | IGFBP-3 and BMI | |
Spearman’s r coefficient | −0.07 | 0.01 | −0.09 | −0.20 | 0.06 | |
p | 0.50 | 0.92 | 0.36 | 0.06 | 0.53 | |
CRA group | IGF-1 and IGFBP-3 |
IGF-1 and cholecalciferol | IGF-1 and calcidiol | IGF-1 and calcitriol | IGF-1 and age | IGF-1 and BMI |
Spearman’s r coefficient | −0.66 | −0.24 | −0.12 | −0.34 | −0.39 | 0.05 |
p | <0.0001 | 0.07 | 0.37 | 0.01 | 0.003 | 0.70 |
CRA group | IGFBP-3 and cholecalciferol | IGFBP-3 and calcidiol | IGFBP-3 and calcitriol | IGFBP-3 and age | IGFBP-3 and BMI | |
Spearman’s r coefficient | 0.10 | 0.01 | 0.22 | 0.15 | 0.19 | |
p | 0.46 | 0.94 | 0.10 | 0.25 | 0.15 | |
Control group | IGF-1 and IGFBP-3 |
IGF-1 and cholecalciferol | IGF-1 and calcidiol | IGF-1 and calcitriol | IGF-1 and age | IGF-1 and BMI |
Spearman’s r coefficient | 0.16 | −0.22 | 0.28 | −0.28 | −0.45 | −0.29 |
p | 0.36 | 0.22 | 0.11 | 0.10 | 0.01 | 0.10 |
Control group | IGFBP-3 and cholecalciferol | IGFBP-3 and calcidiol | IGFBP-3 and calcitriol | IGFBP-3 and age | IGFBP-3 and BMI | |
Spearman’s r coefficient | −0.11 | −0.11 | −0.23 | −0.05 | −0.31 | |
p | 0.52 | 0.52 | 0.19 | 0.76 | 0.07 |
1 IGF-1—insulin-like growth factor-1; 2 IGFBP-3—insulin-like growth factor binding protein-3; 3 CRA—colorectal adenoma, 4 BMI—body mass index.